Overview
Our Commitment
Adamas develops new medicines to improve the lives of people affected by chronic neurologic disorders. About Adamas
ADS-5102 in Levodopa-induced Dyskinesia
Why Aminoadamantanes?
We are developing a chrono-synchronous amantadine therapy for treatment of (LID) in Parkinson's disease. Learn More